Trial · NCT03945175
Results by group66
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 66
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Adult ADHD Investigator Symptom Rating Scale (AISRS) Score at End of Placebo Lead-In | Placebo, Then Mydayis | 37.2 | Standard Deviation 11.4 | score on a scale | |
| Adult ADHD Investigator Symptom Rating Scale (AISRS) Score at End of Mydayis Treatment | Placebo, Then Mydayis | 18.5 | Standard Deviation 8.9 | score on a scale | |
| AISRS: Overall Inattentive (IA) Symptom Subscale Score at End of Placebo Lead-In | Placebo, Then Mydayis | 19.9 | Standard Deviation 6.1 | score on a scale | |
| AISRS: Overall Inattentive (IA) Symptom Subscale Score at End of Mydayis Treatment | Placebo, Then Mydayis | 9.6 | Standard Deviation 4.7 | score on a scale | |
| AISRS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Placebo Lead-In | Placebo, Then Mydayis | 17.3 | Standard Deviation 5.8 | score on a scale | |
| AISRS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Mydayis Treatment | Placebo, Then Mydayis | 8.8 | Standard Deviation 5.0 | score on a scale | |
| Clinical Global Impression-Severity (CGI-S) Scale Score at End of Placebo Lead-In | Placebo, Then Mydayis | 4.6 | Standard Deviation 0.8 | score on a scale | |
| Clinical Global Impression-Severity (CGI-S) Scale Score at End of Mydayis Treatment | Placebo, Then Mydayis | 3.1 | Standard Deviation 1.0 | score on a scale | |
| 14-Hour Post-Dose Time-Sensitive Adult ADHD Symptom Scale (TASS) Score at End of Placebo Lead-In | Placebo, Then Mydayis | 24.6 | Standard Deviation 10.8 | score on a scale | |
| 14-Hour Post-Dose Time-Sensitive Adult ADHD Symptom Scale (TASS) Score at End of Mydayis Treatment | Placebo, Then Mydayis | 16.8 | Standard Deviation 10.8 | score on a scale | |
| 14-hour Post-Dose TASS: Inattentive (IA) Symptom Subscale Score at End of Placebo Lead-In | Placebo, Then Mydayis | 15.4 | Standard Deviation 5.5 | score on a scale | |
| 14-hour Post-Dose TASS: Inattentive (IA) Symptom Subscale Score at End of Mydayis Treatment | Placebo, Then Mydayis | 9.8 | Standard Deviation 6.3 | score on a scale | |
| 14-hour Post-Dose TASS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Placebo Lead-In | Placebo, Then Mydayis | 9.2 | Standard Deviation 5.7 | score on a scale | |
| 14-hour Post-Dose TASS: Hyperactive-Impulsive (HI) Symptom Subscale Score at End of Mydayis Treatment | Placebo, Then Mydayis | 6.9 | Standard Deviation 5.3 | score on a scale | |
| Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) Score at Week 3 | Placebo, Then Mydayis | 68.6 | Standard Deviation 8.9 | T-score | |
| Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) Score at Week 7 | Placebo, Then Mydayis | 58.6 | Standard Deviation 14.9 | T-score | |
| WebNeuro Neurocognitive Assessment - Working Memory Capacity - Recall Span Score at Baseline | Placebo, Then Mydayis | 5.8 | Standard Deviation 2.0 | digits | |
| WebNeuro Neurocognitive Assessment - Working Memory Capacity - Recall Span Score at Week 7 | Placebo, Then Mydayis | 6.4 | Standard Deviation 1.2 | score on a scale | |
| WebNeuro Neurocognitive Assessment - Working Memory Capacity - Working Memory Accuracy at Baseline | Placebo, Then Mydayis | 6.9 | Standard Deviation 3.2 | trials correct | |
| WebNeuro Neurocognitive Assessment - Working Memory Capacity - Working Memory Accuracy at Week 7 | Placebo, Then Mydayis | 7.7 | Standard Deviation 2.1 | trials correct |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03945175/results